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Abstract
In the water maze test, oral administration with 1,2-dilynoleoyl-sn-glycero-3-phosphocholine (DLPhtCho)(5 mg/kg)
alone or DLPhtCho (5 mg/kg) plus 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPhtCho)(5 mg/kg)
significantly shortened the prolonged acquisition latency for rats intraperitoneally injected with scopolamine, with
more efficient effect than (POPhtCho)(5 mg/kg) alone, arachidonic acid (AA)(5 mg/kg) alone, docosahexaenoic acid
(DHA)(5 mg/kg) alone, or 1-palmitoyl-2-linoleil-sn-glycero-3-phosphoserine (PLPhtSer)(5 mg/kg) alone. POPhtCho
(5 mg/kg) alone or DLPhtCho (5 mg/kg) plus POPhtCho (5 mg/kg) also significantly shortened the prolonged
retention latency for rats intraperitoneally injected with scopolamine, but otherwise no significant effect was
obtained with DLPhtCho (5 mg/kg) alone, AA (5 mg/kg) alone, DHA (5 mg/kg) alone, or PLPhtSer (5 mg/kg) alone.
Oral co-administration with DLPhtCho (5 mg/kg) and POPhtCho (5 mg/kg) significantly shortened the acquisition
latency for rats untreated with scopolamine as compared with the latency for administration with polyethylene
glycol (PEG), DLPhtCho alone at doses of 5 and 10 mg/kg, or POPhtCho alone at doses of 5 and 10 mg/kg, while
no efficient effect on the retention latency was obtained. To assess the effect of DLPhtCho and POPhtCho on
cognitive functions for humans, Mini Mental State Examination (MMSE) test was performed in subjects with
cognitive disorders (the average MMSE score, 15). Oral co-intake with DLPhtCho (50 mg) and POPhtCho (45 mg)
once after breakfast everyday raised the score to over 20, corresponding to normal cognitive functions, throughout
5 months after intake, and the increase in the score was significantly greater than that for oral intake with
DLPhtCho (100 mg/day) alone or POPhtCho (90 mg/kg) alone. Taken together, the results of the present study
show that co-intake with DLPhtCho and POPhtCho could enhance learning and memory ability and improve
cognitive disorders for both the animals and humans with a promising efficacy.
Introduction
Accumulating evidence has pointed to a variety of lipids
as a regulatory mediator of cognitive functions. Cis-unsa-
turated free fatty acids such as AA, oleic, linoleic, linole-
nic, and DHA, that are produced by phospholipase A2-
catalyzed hydrolysis of PhtCho [1], are recognized to
serve as a retrograde messenger for expression of long-
term potentiation (LTP), a cellular model of learning and
memory [2]. Those free fatty acids facilitate hippocampal
synaptic transmission by targeting presynaptic nicotinic
ACh receptors under the influence of protein kinase C
(PKC) [3,4]. This accounts for contribution of the free
fatty acids to LTP formation [5,6]. Cis-unsaturated free
fatty acids, accordingly, might enhance learning and
memory ability.
In our earlier studies, DLPhtCho potentiated a7 nico-
tinic ACh receptor responses and facilitated hippocam-
pal synaptic transmission in an a7 nicotinic ACh
receptor-dependent manner [7]. POPhtCho, alterna-
tively, improved scopolamine-induced impairment of
spatial learning and memory for rats, possibly by enhan-
cing long-term depression (LTD), another cellular
model of learning and memory, in concert with
decreased expression of the a-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) receptor
subunit GluR1 on the plasma membrane [8]. Notably,
POPhtCho ameliorated cognitive decline for humans
[8]. PhtChos, thus, could exert its beneficial action
against learning and memory disorders. In addition,
phosphatidylserine (PhtSer) has been also suggested to
serve as a cognitive enhancer, although its effect is still
under discussion [9,10].* Correspondence: tomoyuki@hyo-med.ac.jp
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The present study was conducted to assess the efficacy
of DLPhtCho, POPhtCho, AA, DHA, and PLPhtSer on
learning and memory functions. We show here that co-
intake with DLPhtCho and POPhtCho enhances spatial
learning and memory ability and improves cognitive dis-
orders for both the animals and humans, with more




All procedures have been approved by the Animal Care
and Use Committee at Hyogo College of Medicine and
were in compliance with the National Institutes of
Health Guide for the Care and Use of Laboratory
Animals.
Participants
The study for human was approved by Institutional
Review Board at Hyogo College of Medicine and
informed consent was obtained from all the participants.
Water maze test
A circular plastic water tank with 180 cm in diameter
and 45 cm in deep was used for a water maze test. The
entire inside of the pool was painted black, and the pool
was filled up to 25 cm from the bottom with muddy
water containing India ink at 22°C. A platform (11 cm
in diameter) painted black was placed into water, the
top sinking 1 cm below water surface. The pool was put
in a test room, where there were several marks that rats
were able to see from the pool. The position of the
marks remained unchanged throughout testing. A plat-
form was located in the constant position, i.e., in the
middle of one quadrant, equidistant from the center and
edge of the pool. Wistar rats (male, 7 weeks) facing the
wall of the pool were placed into water at one of 5 posi-
tions selected at random, and time from start to escape
onto the platform (acquisition latency) was measured.
When succeeded, rats were allowed to stay on the plat-
form for 10 s. Scopolamine (1 mg/kg) was intraperitone-
ally injected 30 min before water maze task as a model
of spatial learning and memory disorders. DLPhtCho,
POPhtCho, AA, DHA, and PLPhtSer dissolved with
PEG (final volume, 0.1 ml) or PEG alone (final volume,
0.1 ml) alone was orally administered to rats everyday
throughout experiments from 7 days prior to the begin-
ning of water maze test. Water maze task was per-
formed two trials per day, and the second trial began
2 min after the end of the first trial. Rats received the
task for consecutive 8 days and the acquisition latency
(time form start to arrival onto the plate) was measured.
Eight days later, the platform was removed and the
retention latency (time from the start to arrival to the
place where the platform had been set, 30 s in maxi-
mum) was measured.
MMSE test
MMSE test was performed on 310 subjects (135 males
and 175 females) ranging in age from 59 to 95 years
(average, 76 ± 1.2 years old), who had age-related cogni-
tive disorders before and after oral intake with
DLPhtCho (100 mg/day), extracted from soybean
lecithin, for 21 subjects, POPhtCho (90 mg/day),
extracted from egg lecithin, for 214 subjects, and
DLPhtCho (50 mg/day) plus POPhtCho (45 mg/day) for
75 subjects. Full marks are 30, and less than 20 corre-
sponds to mild cognitive impairment and dementia.
Statistical analysis
Statistical analysis was carried out using Fisher’s Pro-
tected Least Significant Difference (PLSD) test, Dun-
nett’s test, and paired t-test.
Results and discussion
In the water maze test, intraperitoneal injection with
scopolamine markedly prolonged the acquisition latency
(Figure 1A), indicating scopolamine-induced impairment
of spatial learning. Oral administration with DLPhtCho
(5 mg/kg) alone or DLPhtCho (5 mg/kg) plus POPhtCho
(5 mg/kg) significantly shortened the prolonged acquisi-
tion latency (P < 0.001 as compared with the latency for
scopolamine-treated rats with oral administration with
PEG, Fisher’s PLSD test), each reaching similar levels for
sham groups, while no significant effect was obtained with
POPhtCho (5 mg/kg) alone (Figure 1A). Oral administra-
tion with DHA (5 mg/kg) or PLPhtSer (5 mg/kg) also
shortened the prolonged latency, but the effect was not
significant (Figure 1A). No efficient effect was obtained
with AA (5 mg/kg); conversely, AA more prolonged the
acquisition latency (Figure 1A), suggesting that AA might
worsen spatial learning deficits.
Scopolamine also prolonged the retention latency
(Figure 1B), indicating scopolamine-induced impairment
of spatial memory. Notably, POPhtCho (5 mg/kg) alone
or DLPhtCho (5 mg/kg) plus POPhtCho (5 mg/kg) sig-
nificantly shortened the prolonged retention latency,
although DLPhtCho (5 mg/kg) alone had no effect on
it (Figure 1B). No efficient effect was obtained with
AA (5 mg/kg), DHA (5 mg/kg) or PLPhtSer (5 mg/kg)
(Figure 1B).
Cis-unsaturated free fatty acids such as AA and DHA,
systemically applied, are promptly metabolized and
decomposed before arriving in the brain. This may
account for no/less effect of AA or DHA against spatial
learning and memory deficits, even though evidence has
pointed to those lipids as a cognitive enhancer in the
in vitro systems. PLPhtSer here shortened the prolonged
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acquisition latency for rats treated with scopolamine, but
to much lesser extent as compared with the extent for
DLPhtCho alone or DLPhtCho plus POPhtCho, and the
lipid had no effect on the prolonged retention latency.
This may support the note for less efficient effect of PhtSer
on memory or other cognitive functions [10].
In our earlier study, DLPhtCho facilitated hippocam-
pal synaptic transmission by enhancing a7 ACh receptor
responses [7], but POPhtCho, otherwise, enhanced LTD
by reducing expression of AMPA receptor subunit
GluR1 on the plasma membrane [8]. This suggests dif-
ferent actions on learning and memory functions
between DLPhtCho and POPhtCho. In support of this
note, DLPhtCho improved the prolonged acquisition
latency without affecting the prolonged retention latency
and POPhtCho ameliorated the prolonged retention
latency without affecting the prolonged acquisition
latency, and DLPhtCho plus POPhtCho exerted both
the actions.
Amazingly, oral co-administration with DLPhtCho
(5 mg/kg) and POPhtCho (5 mg/kg) significantly shor-
tened the acquisition latency for rats untreated with sco-
polamine as compared with the latency for
administration with PEG, DLPhtCho alone at doses of 5
and 10 mg/kg, or POPhtCho alone at doses of 5 and 10
mg/kg (P < 0.001, Fisher’s PLSD test)(Figure 2A). Oral
administration with POPhtCho alone at doses of 5 and
10 mg/kg or DLPhtCho (5 mg/kg) plus POPhtCho (5
mg/kg) also shortened the retention latency for
untreated rats, but no significant effect was obtained
(Figure 2B). It is indicated from these results that
DLPhtCho and/or POPhtCho could serve as an enhan-
cer of learning and memory for normal rats.
PhtCho, systemically applied and conveyed in the brain,
is hydrolyzed into cis-unsaturated free fatty acid and lyso-
phosphatidylcholine by phospholipase A2 or into choline
and phosphatidic acid by phospholipase D, followed by
further hydrolysis into cis-unsaturated free fatty acid and
lysophosphatidic acid by phospholipase A2. As previously
shown, cis-unsaturated free fatty acid, lysophosphatidyl-
choline, and lysophosphatidic acid persistently potentiate
nicotinic ACh receptor responses [3,11,12], to induce an
LTP-like long-lasting facilitation of hippocampal synaptic
transmission [4,13] or LTP [5,6]. In addition, choline
activates a7 nicotinic ACh receptors as a selective ago-
nist [14], thereby stimulating the cholinergic systems clo-
sely related to cognitive functions. PhtCho metabolites as
well as unhydrolyzed PhtCho by itself, accordingly, could
enhance learning and memory ability or ameliorate learn-
ing and memory impairment.
We finally examined the effect of DLPhtCho and/or
POPhtCho on cognitive disorders for humans. Of all the
Figure 1 Effect of DLPhtCho and/or POPhtCho on scopolamine-
induced impairment of spatial learning and memory. Rats were
orally administered with PEG, AA, DHA, PLPhtSer (PS), DLPhtCho
(DLPC), POPhtCho (POPC), or DLPhtCho plus POPhtCho (DL & PO) at
a dose of 5 mg/kg everyday throughout experiments from 7 days
prior to the beginning of water maze test. Saline or scopolamine
(1 mg/kg) was intraperitoneally injected 30 min prior to water maze
task. (A) Each point represents the mean (± SEM) acquisition latency
from consecutive 2 days (n = 6). (B) Each column represents the
mean (± SEM) retention latency (n = 6). P values, Dunnett’s test.
Sham, intraperitoneal injection with saline and oral administration
with PEG; Sco treatment + PEG, intraperitoneal injection with
scopolamine and oral administration with PEG; Sco treatment + AA,
intraperitoneal injection with scopolamine and oral administration
with AA; Sco treatment + DHA, intraperitoneal injection with
scopolamine and oral administration with DHA; Sco treatment + PS,
intraperitoneal injection with scopolamine and oral administration
with PLPhtSer; Sco treatment + DLPC, intraperitoneal injection with
scopolamine and oral administration with DLPhtCho; Sco treatment +
POPC, intraperitoneal injection with scopolamine and oral
administration with POPhtCho; Sco treatment + DL & PO,
intraperitoneal injection with scopolamine and oral administration
with DLPhtCho plus POPhtCho.
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subjects (310) tested here approximately 65% belonged
in mild cognitive impairment and dementia. For 75 sub-
jects with oral intake with DLPhtCho and POPhtCho, the
average MMSE score before intake was 14.7 ± 0.7 (Figure
3A). Oral co-intake with DLPhtCho (50 mg/day) and
POPhtCho (45 mg/day) once after breakfast everyday sig-
nificantly raised MMSE scores, the average score reach-
ing over 20, i.e., normal cognitive functions, throughout
5 months after intake (Figure 3A). An MMSE score rise 5
months after co-intake with DLPhtCho (50 mg/day) and
POPhtCho (45 mg/day) was significantly greater than the
rise 5 months after DLPhtCho (100 mg/day) alone and
POPhtCho (90 mg/day) alone (Figure 3B). These results
indicate that co-intake with DLPhtCho and POPhtCho is
capable of ameliorating mild cognitive impairment and
Figure 2 Effect of DLPhtCho and/or POPhtCho on spatial
learning and memory for normal rats. Rats were orally
administered with PEG, DLPhtCho (DLPC), POPhtCho (POPC), or
DLPhtCho plus POPhtCho (DL & PO) everyday throughout
experiments from 7 days prior to the beginning of water maze test.
(A) Each point represents the mean (± SEM) acquisition latency from
consecutive 2 days (n = 6). (B) Each column represents the mean
(± SEM) retention latency (n = 6). + PEG, oral administration with
PEG; + DLPC (5), oral administration with DLPhtCho (5 mg/kg); +
DLPC (10), oral administration with DLPhtCho (10 mg/kg); + POPC
(5), oral administration with POPhtCho (5 mg/kg); + POPC (10), oral
administration with POPhtCho (10 mg/kg); + DL (5) & PO (5), oral
administration with DLPhtCho (5 mg/kg) plus POPhtCho (5 mg/kg).
Figure 3 Effect of DLPhtCho and/or POPhtCho on cognitive
disorders for humans. MMSE test was carried out once a month
before and after oral intake with DLPhtCho, POPhtCho, and
DLPhtCho plus POPhtCho once after breakfast every day. (A) Each
point represents the mean (± SEM) MMSE score at the periods as
indicated for 75 subjects with oral intake with DLPhtCho (50 mg/
day) plus POPhtCho (45 mg/kg). **P < 0.001 as compared with the
score before oral intake, paired t-test. (B) An MMSE score rise was
calculated 5 months after oral intake with DLPhtCho (100 mg/day)
alone for 21 subjects, POPhtCho (90 mg/day) alone for 214 subjects,
and DLPhtCho (50 mg/day) plus POPhtCho (45 mg/kg) for 75
subjects. Each column represents the mean (± SEM) MMSE rise.
P values, Dunnett’s test.
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dementia for humans, with more efficient effect than
each alone. This also suggests that continuous intake
with DLPhtCho and POPhtCho from a diet or dietary
supplements could prevent dementia.
In conclusion, the results of the present study show
that co-intake with DLPhtCho and POPhtCho improves
spatial learning and memory impairment for rats treated
with scopolamine, enhances spatial learning and mem-
ory ability for normal rats, and ameliorates mild cogni-
tive impairment and dementia for humans, with more
beneficial effect than each alone. DLPhtCho and
POPhtCho, thus, could prevent and improve dementia
with a promising efficacy.
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